Jane Shingles, PhD

Leeds Teaching Hospitals NHS Trust, United Kingdom

Poster(s):

• 1437 - Effect of targeted treatment on IGHV subset #2 and #8 patients in CLL: Comparison of MRD defined Ibrutinib plus Venetoclax treatment to the Ibrutinib and FCR arms of the FLAIR Trial